2nd Quarter - Report

ONCOLOGY NURSING SOCIETY for ONCOLOGY NURSING SOCIETY

Period 2nd Quarter 2019 Filed Jul 22, 2019 Signed by Michele McCorkle

Official filing
Firm
ONCOLOGY NURSING SOCIETY
Client
ONCOLOGY NURSING SOCIETY
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education & Treatment Act PCHETA (H.R 647); Cancer Drug Parity Act (H.R. 1730/S. 741);Title VIII Nursing Reauthorization Act (HR 728); Lymphedema Treatment Act (H.R. 1948/S. 518); Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act"; Clinical Treatment Act (H.R. 913)

LobbyistCovered position, as disclosed
ALEC STONE Clinton White House, Women's Health Initiatives
DONNA SLINGLUFF SWEENEY New —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 741 (116th), S. 518 (116th), H.R. 1948 (116th), H.R. 647 (116th), H.R. 1730 (116th), H.R. 728 (116th), H.R. 913 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.